131 related articles for article (PubMed ID: 3381236)
1. Radioreceptor assay and high-performance liquid chromatography yield similar results for serum thioridazine and its major metabolites.
Rao ML; Brown WA; Wagner R
Ther Drug Monit; 1988; 10(2):184-7. PubMed ID: 3381236
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype.
von Bahr C; Movin G; Nordin C; Lidén A; Hammarlund-Udenaes M; Hedberg A; Ring H; Sjöqvist F
Clin Pharmacol Ther; 1991 Mar; 49(3):234-40. PubMed ID: 2007317
[TBL] [Abstract][Full Text] [Related]
3. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
Cohen BM; Lipinski JF; Waternaux C
Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
[TBL] [Abstract][Full Text] [Related]
4. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
Eap CB; Souche A; Koeb L; Baumann P
Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of thioridazine, its major metabolites and serum neuroleptic-like activities in schizophrenics with and without tardive dyskinesia.
Widerlöv E; Häggström JE; Kilts CD; Andersson U; Breese GR; Mailman RB
Acta Psychiatr Scand; 1982 Oct; 66(4):294-305. PubMed ID: 7148482
[TBL] [Abstract][Full Text] [Related]
6. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
[No Abstract] [Full Text] [Related]
7. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
[TBL] [Abstract][Full Text] [Related]
8. Disparate serum thioridazine concentrations: liquid chromatography versus radioreceptor assay.
Linnoila M; Rosenblatt JE; Jeste D; Skinner T; Potter WZ; Wyatt RJ
Acta Pharmacol Toxicol (Copenh); 1982 Jan; 50(1):25-9. PubMed ID: 7064715
[TBL] [Abstract][Full Text] [Related]
9. A pilot of plasma thioridazine and metabolites in chronically treated patients.
Papadopoulos AS; Chand TG; Crammer JL; Lader S
Br J Psychiatry; 1980 Jun; 136():591-6. PubMed ID: 7388266
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment.
Daniel WA; Syrek M; Mach A; Wójcikowski J; Boksa J
Pol J Pharmacol; 1997; 49(6):439-52. PubMed ID: 9566048
[TBL] [Abstract][Full Text] [Related]
11. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients.
Shvartsburd A; Nwokeafor V; Smith RC
Psychopharmacology (Berl); 1984; 82(1-2):55-61. PubMed ID: 6420831
[TBL] [Abstract][Full Text] [Related]
13. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
14. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
[TBL] [Abstract][Full Text] [Related]
15. The strategy and value of neuroleptic drug monitoring.
Curry SH
J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
[TBL] [Abstract][Full Text] [Related]
16. High plasma concentrations of metoclopramide are not detected by radioreceptor assay.
Stanley M; Wazer D
Neuropsychobiology; 1983; 10(2-3):108-10. PubMed ID: 6674818
[TBL] [Abstract][Full Text] [Related]
17. Plasma propranolol levels and their effect on plasma thioridazine and haloperidol concentrations.
Greendyke RM; Kanter DR
J Clin Psychopharmacol; 1987 Jun; 7(3):178-82. PubMed ID: 3597804
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous assay of thioridazine and its major metabolites in plasma at single dosage levels with a novel report of two ring sulfoxides of thioridazine.
Wells CE; Juenge EC; Furman WB
J Pharm Sci; 1983 Jun; 72(6):622-5. PubMed ID: 6875822
[TBL] [Abstract][Full Text] [Related]
19. No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
Dorado P; Berecz R; Peñas-Lledó EM; de la Rubia A; Llerena A
Eur J Clin Pharmacol; 2007 May; 63(5):527-8. PubMed ID: 17345072
[No Abstract] [Full Text] [Related]
20. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients.
Tune LE; Creese I; DePaulo JR; Slavney PR; Snyder SH
J Nerv Ment Dis; 1981 Jan; 169(1):60-3. PubMed ID: 6108981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
